Global Hepatitis A Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hepatitis A Vaccine market size is predicted to grow from US$ 749 million in 2025 to US$ 860 million in 2031; it is expected to grow at a CAGR of 2.3% from 2025 to 2031.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hepatitis A Vaccine Industry Forecast” looks at past sales and reviews total world Hepatitis A Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Hepatitis A Vaccine sales for 2025 through 2031. With Hepatitis A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hepatitis A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hepatitis A Vaccine market?
What factors are driving Hepatitis A Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis A Vaccine market opportunities vary by end market size?
How does Hepatitis A Vaccine break out by Type, by Application?
The global Hepatitis A Vaccine market size is predicted to grow from US$ 749 million in 2025 to US$ 860 million in 2031; it is expected to grow at a CAGR of 2.3% from 2025 to 2031.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hepatitis A Vaccine Industry Forecast” looks at past sales and reviews total world Hepatitis A Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Hepatitis A Vaccine sales for 2025 through 2031. With Hepatitis A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hepatitis A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Inactivated Vaccine
- Live Attenuated Vaccine
- Government Institution
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- KM Biologics
- IMBCAMS
- Convac
What is the 10-year outlook for the global Hepatitis A Vaccine market?
What factors are driving Hepatitis A Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis A Vaccine market opportunities vary by end market size?
How does Hepatitis A Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis A Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hepatitis A Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hepatitis A Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Hepatitis A Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Hepatitis A Vaccine Sales by Type
2.3.1 Global Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hepatitis A Vaccine Sale Price by Type (2020-2025)
2.4 Hepatitis A Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Hepatitis A Vaccine Sales by Application
2.5.1 Global Hepatitis A Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Hepatitis A Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hepatitis A Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Hepatitis A Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Hepatitis A Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Hepatitis A Vaccine Revenue by Company (2020-2025)
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEPATITIS A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Hepatitis A Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Hepatitis A Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hepatitis A Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hepatitis A Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Hepatitis A Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hepatitis A Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hepatitis A Vaccine Sales Growth
4.4 APAC Hepatitis A Vaccine Sales Growth
4.5 Europe Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Hepatitis A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Hepatitis A Vaccine Sales by Country
5.1.1 Americas Hepatitis A Vaccine Sales by Country (2020-2025)
5.1.2 Americas Hepatitis A Vaccine Revenue by Country (2020-2025)
5.2 Americas Hepatitis A Vaccine Sales by Type (2020-2025)
5.3 Americas Hepatitis A Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A Vaccine Sales by Region
6.1.1 APAC Hepatitis A Vaccine Sales by Region (2020-2025)
6.1.2 APAC Hepatitis A Vaccine Revenue by Region (2020-2025)
6.2 APAC Hepatitis A Vaccine Sales by Type (2020-2025)
6.3 APAC Hepatitis A Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatitis A Vaccine by Country
7.1.1 Europe Hepatitis A Vaccine Sales by Country (2020-2025)
7.1.2 Europe Hepatitis A Vaccine Revenue by Country (2020-2025)
7.2 Europe Hepatitis A Vaccine Sales by Type (2020-2025)
7.3 Europe Hepatitis A Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Hepatitis A Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hepatitis A Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Hepatitis A Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Hepatitis A Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Hepatitis A Vaccine
10.4 Industry Chain Structure of Hepatitis A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A Vaccine Distributors
11.3 Hepatitis A Vaccine Customer
12 WORLD FORECAST REVIEW FOR HEPATITIS A VACCINE BY GEOGRAPHIC REGION
12.1 Global Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Hepatitis A Vaccine Forecast by Region (2026-2031)
12.1.2 Global Hepatitis A Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hepatitis A Vaccine Forecast by Type (2026-2031)
12.7 Global Hepatitis A Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis A Vaccine Product Portfolios and Specifications
13.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Hepatitis A Vaccine Product Portfolios and Specifications
13.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Hepatitis A Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Hepatitis A Vaccine Product Portfolios and Specifications
13.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Hepatitis A Vaccine Product Portfolios and Specifications
13.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolios and Specifications
13.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Hepatitis A Vaccine Product Portfolios and Specifications
13.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Hepatitis A Vaccine Product Portfolios and Specifications
13.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Hepatitis A Vaccine Product Portfolios and Specifications
13.9.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis A Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hepatitis A Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hepatitis A Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Hepatitis A Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Hepatitis A Vaccine Sales by Type
2.3.1 Global Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hepatitis A Vaccine Sale Price by Type (2020-2025)
2.4 Hepatitis A Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Hepatitis A Vaccine Sales by Application
2.5.1 Global Hepatitis A Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Hepatitis A Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hepatitis A Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Hepatitis A Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Hepatitis A Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Hepatitis A Vaccine Revenue by Company (2020-2025)
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEPATITIS A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Hepatitis A Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Hepatitis A Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hepatitis A Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hepatitis A Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Hepatitis A Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hepatitis A Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hepatitis A Vaccine Sales Growth
4.4 APAC Hepatitis A Vaccine Sales Growth
4.5 Europe Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Hepatitis A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Hepatitis A Vaccine Sales by Country
5.1.1 Americas Hepatitis A Vaccine Sales by Country (2020-2025)
5.1.2 Americas Hepatitis A Vaccine Revenue by Country (2020-2025)
5.2 Americas Hepatitis A Vaccine Sales by Type (2020-2025)
5.3 Americas Hepatitis A Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A Vaccine Sales by Region
6.1.1 APAC Hepatitis A Vaccine Sales by Region (2020-2025)
6.1.2 APAC Hepatitis A Vaccine Revenue by Region (2020-2025)
6.2 APAC Hepatitis A Vaccine Sales by Type (2020-2025)
6.3 APAC Hepatitis A Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatitis A Vaccine by Country
7.1.1 Europe Hepatitis A Vaccine Sales by Country (2020-2025)
7.1.2 Europe Hepatitis A Vaccine Revenue by Country (2020-2025)
7.2 Europe Hepatitis A Vaccine Sales by Type (2020-2025)
7.3 Europe Hepatitis A Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Hepatitis A Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hepatitis A Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Hepatitis A Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Hepatitis A Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Hepatitis A Vaccine
10.4 Industry Chain Structure of Hepatitis A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A Vaccine Distributors
11.3 Hepatitis A Vaccine Customer
12 WORLD FORECAST REVIEW FOR HEPATITIS A VACCINE BY GEOGRAPHIC REGION
12.1 Global Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Hepatitis A Vaccine Forecast by Region (2026-2031)
12.1.2 Global Hepatitis A Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hepatitis A Vaccine Forecast by Type (2026-2031)
12.7 Global Hepatitis A Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis A Vaccine Product Portfolios and Specifications
13.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Hepatitis A Vaccine Product Portfolios and Specifications
13.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Hepatitis A Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Hepatitis A Vaccine Product Portfolios and Specifications
13.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Hepatitis A Vaccine Product Portfolios and Specifications
13.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolios and Specifications
13.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Hepatitis A Vaccine Product Portfolios and Specifications
13.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Hepatitis A Vaccine Product Portfolios and Specifications
13.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Hepatitis A Vaccine Product Portfolios and Specifications
13.9.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hepatitis A Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hepatitis A Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 6. Global Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Hepatitis A Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Hepatitis A Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Hepatitis A Vaccine Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Hepatitis A Vaccine Sale by Application (2020-2025) & (K Unit)
Table 11. Global Hepatitis A Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Hepatitis A Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Hepatitis A Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Hepatitis A Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Hepatitis A Vaccine Sales by Company (2020-2025) & (K Unit)
Table 16. Global Hepatitis A Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Hepatitis A Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Hepatitis A Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Hepatitis A Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Hepatitis A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Hepatitis A Vaccine Products Offered
Table 22. Hepatitis A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Hepatitis A Vaccine Sales by Geographic Region (2020-2025) & (K Unit)
Table 26. Global Hepatitis A Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Hepatitis A Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Hepatitis A Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Hepatitis A Vaccine Sales by Country/Region (2020-2025) & (K Unit)
Table 30. Global Hepatitis A Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Hepatitis A Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Hepatitis A Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 34. Americas Hepatitis A Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Hepatitis A Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 37. Americas Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 38. APAC Hepatitis A Vaccine Sales by Region (2020-2025) & (K Unit)
Table 39. APAC Hepatitis A Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Hepatitis A Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 42. APAC Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 43. Europe Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 44. Europe Hepatitis A Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 46. Europe Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 47. Middle East & Africa Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 48. Middle East & Africa Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 50. Middle East & Africa Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 51. Key Market Drivers & Growth Opportunities of Hepatitis A Vaccine
Table 52. Key Market Challenges & Risks of Hepatitis A Vaccine
Table 53. Key Industry Trends of Hepatitis A Vaccine
Table 54. Hepatitis A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Hepatitis A Vaccine Distributors List
Table 57. Hepatitis A Vaccine Customer List
Table 58. Global Hepatitis A Vaccine Sales Forecast by Region (2026-2031) & (K Unit)
Table 59. Global Hepatitis A Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Hepatitis A Vaccine Sales Forecast by Country (2026-2031) & (K Unit)
Table 61. Americas Hepatitis A Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Hepatitis A Vaccine Sales Forecast by Region (2026-2031) & (K Unit)
Table 63. APAC Hepatitis A Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Hepatitis A Vaccine Sales Forecast by Country (2026-2031) & (K Unit)
Table 65. Europe Hepatitis A Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Hepatitis A Vaccine Sales Forecast by Country (2026-2031) & (K Unit)
Table 67. Middle East & Africa Hepatitis A Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Hepatitis A Vaccine Sales Forecast by Type (2026-2031) & (K Unit)
Table 69. Global Hepatitis A Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Hepatitis A Vaccine Sales Forecast by Application (2026-2031) & (K Unit)
Table 71. Global Hepatitis A Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GSK Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Hepatitis A Vaccine Product Portfolios and Specifications
Table 74. GSK Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. Merck Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Hepatitis A Vaccine Product Portfolios and Specifications
Table 79. Merck Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Sanofi Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Hepatitis A Vaccine Product Portfolios and Specifications
Table 84. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Sinovac Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Sinovac Hepatitis A Vaccine Product Portfolios and Specifications
Table 89. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Sinovac Main Business
Table 91. Sinovac Latest Developments
Table 92. Zhejiang Pukang Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Zhejiang Pukang Hepatitis A Vaccine Product Portfolios and Specifications
Table 94. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Zhejiang Pukang Main Business
Table 96. Zhejiang Pukang Latest Developments
Table 97. Changchun Institute of Biological Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Changchun Institute of Biological Hepatitis A Vaccine Product Portfolios and Specifications
Table 99. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Changchun Institute of Biological Main Business
Table 101. Changchun Institute of Biological Latest Developments
Table 102. KM Biologics Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Hepatitis A Vaccine Product Portfolios and Specifications
Table 104. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. IMBCAMS Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. IMBCAMS Hepatitis A Vaccine Product Portfolios and Specifications
Table 109. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. IMBCAMS Main Business
Table 111. IMBCAMS Latest Developments
Table 112. Convac Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Convac Hepatitis A Vaccine Product Portfolios and Specifications
Table 114. Convac Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Convac Main Business
Table 116. Convac Latest Developments
Table 1. Hepatitis A Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hepatitis A Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 6. Global Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Hepatitis A Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Hepatitis A Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Hepatitis A Vaccine Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Hepatitis A Vaccine Sale by Application (2020-2025) & (K Unit)
Table 11. Global Hepatitis A Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Hepatitis A Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Hepatitis A Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Hepatitis A Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Hepatitis A Vaccine Sales by Company (2020-2025) & (K Unit)
Table 16. Global Hepatitis A Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Hepatitis A Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Hepatitis A Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Hepatitis A Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Hepatitis A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Hepatitis A Vaccine Products Offered
Table 22. Hepatitis A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Hepatitis A Vaccine Sales by Geographic Region (2020-2025) & (K Unit)
Table 26. Global Hepatitis A Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Hepatitis A Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Hepatitis A Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Hepatitis A Vaccine Sales by Country/Region (2020-2025) & (K Unit)
Table 30. Global Hepatitis A Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Hepatitis A Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Hepatitis A Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 34. Americas Hepatitis A Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Hepatitis A Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 37. Americas Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 38. APAC Hepatitis A Vaccine Sales by Region (2020-2025) & (K Unit)
Table 39. APAC Hepatitis A Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Hepatitis A Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 42. APAC Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 43. Europe Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 44. Europe Hepatitis A Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 46. Europe Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 47. Middle East & Africa Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 48. Middle East & Africa Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 50. Middle East & Africa Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 51. Key Market Drivers & Growth Opportunities of Hepatitis A Vaccine
Table 52. Key Market Challenges & Risks of Hepatitis A Vaccine
Table 53. Key Industry Trends of Hepatitis A Vaccine
Table 54. Hepatitis A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Hepatitis A Vaccine Distributors List
Table 57. Hepatitis A Vaccine Customer List
Table 58. Global Hepatitis A Vaccine Sales Forecast by Region (2026-2031) & (K Unit)
Table 59. Global Hepatitis A Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Hepatitis A Vaccine Sales Forecast by Country (2026-2031) & (K Unit)
Table 61. Americas Hepatitis A Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Hepatitis A Vaccine Sales Forecast by Region (2026-2031) & (K Unit)
Table 63. APAC Hepatitis A Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Hepatitis A Vaccine Sales Forecast by Country (2026-2031) & (K Unit)
Table 65. Europe Hepatitis A Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Hepatitis A Vaccine Sales Forecast by Country (2026-2031) & (K Unit)
Table 67. Middle East & Africa Hepatitis A Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Hepatitis A Vaccine Sales Forecast by Type (2026-2031) & (K Unit)
Table 69. Global Hepatitis A Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Hepatitis A Vaccine Sales Forecast by Application (2026-2031) & (K Unit)
Table 71. Global Hepatitis A Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GSK Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Hepatitis A Vaccine Product Portfolios and Specifications
Table 74. GSK Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. Merck Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Hepatitis A Vaccine Product Portfolios and Specifications
Table 79. Merck Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Sanofi Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Hepatitis A Vaccine Product Portfolios and Specifications
Table 84. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Sinovac Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Sinovac Hepatitis A Vaccine Product Portfolios and Specifications
Table 89. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Sinovac Main Business
Table 91. Sinovac Latest Developments
Table 92. Zhejiang Pukang Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Zhejiang Pukang Hepatitis A Vaccine Product Portfolios and Specifications
Table 94. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Zhejiang Pukang Main Business
Table 96. Zhejiang Pukang Latest Developments
Table 97. Changchun Institute of Biological Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Changchun Institute of Biological Hepatitis A Vaccine Product Portfolios and Specifications
Table 99. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Changchun Institute of Biological Main Business
Table 101. Changchun Institute of Biological Latest Developments
Table 102. KM Biologics Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. KM Biologics Hepatitis A Vaccine Product Portfolios and Specifications
Table 104. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. KM Biologics Main Business
Table 106. KM Biologics Latest Developments
Table 107. IMBCAMS Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. IMBCAMS Hepatitis A Vaccine Product Portfolios and Specifications
Table 109. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. IMBCAMS Main Business
Table 111. IMBCAMS Latest Developments
Table 112. Convac Basic Information, Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Convac Hepatitis A Vaccine Product Portfolios and Specifications
Table 114. Convac Hepatitis A Vaccine Sales (K Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Convac Main Business
Table 116. Convac Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hepatitis A Vaccine
Figure 2. Hepatitis A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis A Vaccine Sales Growth Rate 2020-2031 (K Unit)
Figure 7. Global Hepatitis A Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hepatitis A Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hepatitis A Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Hepatitis A Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Inactivated Vaccine
Figure 12. Product Picture of Live Attenuated Vaccine
Figure 13. Global Hepatitis A Vaccine Sales Market Share by Type in 2025
Figure 14. Global Hepatitis A Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Hepatitis A Vaccine Consumed in Government Institution
Figure 16. Global Hepatitis A Vaccine Market: Government Institution (2020-2025) & (K Unit)
Figure 17. Hepatitis A Vaccine Consumed in Private Sector
Figure 18. Global Hepatitis A Vaccine Market: Private Sector (2020-2025) & (K Unit)
Figure 19. Hepatitis A Vaccine Consumed in Other
Figure 20. Global Hepatitis A Vaccine Market: Other (2020-2025) & (K Unit)
Figure 21. Global Hepatitis A Vaccine Sale Market Share by Application (2024)
Figure 22. Global Hepatitis A Vaccine Revenue Market Share by Application in 2025
Figure 23. Hepatitis A Vaccine Sales by Company in 2025 (K Unit)
Figure 24. Global Hepatitis A Vaccine Sales Market Share by Company in 2025
Figure 25. Hepatitis A Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Hepatitis A Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Hepatitis A Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Hepatitis A Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 30. Americas Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 32. APAC Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 34. Europe Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 36. Middle East & Africa Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Hepatitis A Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Hepatitis A Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Hepatitis A Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Hepatitis A Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Hepatitis A Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Hepatitis A Vaccine
Figure 75. Industry Chain Structure of Hepatitis A Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Hepatitis A Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Hepatitis A Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Hepatitis A Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Hepatitis A Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Hepatitis A Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Hepatitis A Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Hepatitis A Vaccine
Figure 2. Hepatitis A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis A Vaccine Sales Growth Rate 2020-2031 (K Unit)
Figure 7. Global Hepatitis A Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hepatitis A Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hepatitis A Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Hepatitis A Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Inactivated Vaccine
Figure 12. Product Picture of Live Attenuated Vaccine
Figure 13. Global Hepatitis A Vaccine Sales Market Share by Type in 2025
Figure 14. Global Hepatitis A Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Hepatitis A Vaccine Consumed in Government Institution
Figure 16. Global Hepatitis A Vaccine Market: Government Institution (2020-2025) & (K Unit)
Figure 17. Hepatitis A Vaccine Consumed in Private Sector
Figure 18. Global Hepatitis A Vaccine Market: Private Sector (2020-2025) & (K Unit)
Figure 19. Hepatitis A Vaccine Consumed in Other
Figure 20. Global Hepatitis A Vaccine Market: Other (2020-2025) & (K Unit)
Figure 21. Global Hepatitis A Vaccine Sale Market Share by Application (2024)
Figure 22. Global Hepatitis A Vaccine Revenue Market Share by Application in 2025
Figure 23. Hepatitis A Vaccine Sales by Company in 2025 (K Unit)
Figure 24. Global Hepatitis A Vaccine Sales Market Share by Company in 2025
Figure 25. Hepatitis A Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Hepatitis A Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Hepatitis A Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Hepatitis A Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 30. Americas Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 32. APAC Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 34. Europe Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Hepatitis A Vaccine Sales 2020-2025 (K Unit)
Figure 36. Middle East & Africa Hepatitis A Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Hepatitis A Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Hepatitis A Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Hepatitis A Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Hepatitis A Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Hepatitis A Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Hepatitis A Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Hepatitis A Vaccine
Figure 75. Industry Chain Structure of Hepatitis A Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Hepatitis A Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Hepatitis A Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Hepatitis A Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Hepatitis A Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Hepatitis A Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Hepatitis A Vaccine Revenue Market Share Forecast by Application (2026-2031)
